Mumbai, June 11 (PTI): Nestle India today challenged in Bombay High Court food authorities' orders banning nine variants of Maggi noodles in the country.
The appeal against the impugned orders, passed by the authorities in Delhi and Maharashtra, was mentioned verbally by the company's counsel before a division bench of Justices V.M. Kanade and B.P. Colabawalla.
The court has posted the matter for hearing tomorrow.
The lawyer urged the court to hear the matter "urgently", saying Nestle India had been suffering huge losses because of the orders to withdraw and recall Maggi variants following the presence of excess lead in some samples.
The company pleaded that the court quash the June 5 order of Delhi-based Food Safety and Standards Authority of India (FSSAI) and its chief executive officer asking the company to withdraw all nine variants of Maggi.
The Nestle lawyer also prayed for setting aside an order by the Maharashtra commissioner of food safety banning Maggi in the state.
The company described as "incorrect" the application of standards or tolerance limits by the authorities while conducting the tests for the presence of lead.
The lawyer denied any misbranding or violation of packaging and labelling, saying the company had on its own conducted tests of products since October 2014 and found them to be of standard quality.
He attached copies of the tests to the appeal.
The US Food and Drug Administration is also testing samples of Maggi.
"We have been made aware that the FDA has taken samples of Maggi noodles manufactured in India from third-party importers' containers for testing," a Nestle spokesperson said.
Nestle does not import, market or distribute Maggi noodles in the US. Any Maggi noodle products in US stores are sourced by retailers or imported through third parties.
Drug firm Sandoz Inc is recalling over 1 lakh Mumbai-made Centrizine tablets in the US. A company spokesperson said the tablets were not sold in India.